Cite
IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma.
MLA
Ogawa, H., et al. “IκB Kinase β Inhibitor IMD-0354 Suppresses Airway Remodelling in a Dermatophagoides Pteronyssinus-Sensitized Mouse Model of Chronic Asthma.” Clinical & Experimental Allergy, vol. 41, no. 1, Jan. 2011, pp. 104–15. EBSCOhost, https://doi.org/10.1111/j.1365-2222.2010.03564.x.
APA
Ogawa, H., Azuma, M., Muto, S., Nishioka, Y., Honjo, A., Tezuka, T., Uehara, H., Izumi, K., Itai, A., & Sone, S. (2011). IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma. Clinical & Experimental Allergy, 41(1), 104–115. https://doi.org/10.1111/j.1365-2222.2010.03564.x
Chicago
Ogawa, H., M. Azuma, S. Muto, Y. Nishioka, A. Honjo, T. Tezuka, H. Uehara, K. Izumi, A. Itai, and S. Sone. 2011. “IκB Kinase β Inhibitor IMD-0354 Suppresses Airway Remodelling in a Dermatophagoides Pteronyssinus-Sensitized Mouse Model of Chronic Asthma.” Clinical & Experimental Allergy 41 (1): 104–15. doi:10.1111/j.1365-2222.2010.03564.x.